Medical Writers Wanted — Ongoing Research-Backed Compound Articles (Long-Term, Bylined)

We are building an ongoing content pipeline of research-backed educational articles on peptides and related compounds, and we are hiring multiple freelance medical writers to join our roster. This is long-term work, paid per article, with consistent volume for writers who establish strong fit. Articles are 1,500-word narrative literature reviews on individual compounds — peptides, incretin-based therapies (GLP-1, GLP-1/GIP, and triple agonists), growth-hormone-axis peptides, recovery compounds, and emerging metabolic and longevity research compounds. Each article is written for an educated general reader and built from primary literature. The articles are published on a research-use-only compound marketplace, where editorial content lives alongside product listings. Writers should be comfortable with that context and able to produce conservative, citation-heavy research writing — not marketing copy. What you'll do Research and write 1,500-word narrative literature reviews on assigned compounds Source 8–12 primary citations per article from PubMed, ClinicalTrials.gov, PubChem, and NIH resources Write in conservative, research-oriented language ("investigated for," "studied in," "associated with") — no marketing claims or promotional phrasing Distinguish between preclinical, clinical, and approved-indication evidence within each article Deliver clean drafts ready for editorial review and publication Verify that every citation directly supports the claim it is attached to What you bring Background in pharmacology, pharmacy (PharmD), biochemistry, endocrinology, medical writing, or a related scientific discipline Demonstrated ability to read and accurately summarize primary scientific literature Strong written English and the ability to write for an educated non-specialist audience Citation discipline — fabricated, hallucinated, or misattributed citations are an automatic disqualification Comfort with the editorial context (research-use-only compound marketplace, conservative claims posture, articles bylined under the writer's real name) Byline and context Articles are published under the writer's real name as the author. This is a meaningful professional commitment we take seriously on our end: Editorial tone is strictly research-education, not marketing. Promotional phrasing is rejected at the editor level. Writers review and approve the final version of each article before it goes live. The site is a research-use-only compound marketplace combining product listings with editorial content. Writers should be comfortable having their name on conservative, citation-heavy educational content in that context. How we onboard Every writer starts with either: A paid trial article on a compound of our choosing (paid at the agreed per-article rate), or A relevant existing writing sample — a peptide or research-compound piece you've already produced — that demonstrates your voice, citation discipline, and rigor If the trial piece or sample meets our standards, we move directly into ongoing assignments. Compensation $300–$500 per 1,500-word article, depending on experience, scientific background, and demonstrated fit. Writers with strong clinical-evidence interpretation skills (clinical-trial literature, approved-indication compounds) generally land at the higher end of the range. Trial-piece rate and ongoing rate are negotiated separately. Please include in your proposal A brief note on your scientific background and writing experience One or two writing samples that demonstrate citation discipline and research-oriented tone (links or attachments — peptide-space samples preferred but not required) Your per-article rate Any subject-matter experience with peptides, GLP-class compounds, growth hormone axis, or research compounds Whether you are comfortable having your real name published as the byline on articles appearing on a research-use-only compound marketplace Proposals that do not address point 5 will not be considered. We are looking for writers who have thought carefully about this commitment.